Fenfluramine for the Treatment of Dravet Syndrome and Lennox Gastaut Syndrome: A Review

被引:0
作者
Douglas R. Nordli
Fernando N. Galan
机构
[1] Nemours Children’s Health,
来源
Current Treatment Options in Neurology | 2022年 / 24卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:631 / 640
页数:9
相关论文
共 30 条
  • [1] Sultana B(2021)Incidence and prevalence of drug-resistant epilepsy: a systematic review and meta-analysis Neurology 96 805-817
  • [2] Cross JH(2021)Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome Seizure 93 154-159
  • [3] Fuller RW(1988)Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release Pharmacol Biochem Behav 30 715-721
  • [4] Snoddy HD(2015)Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine PLoS ONE 10 624-588
  • [5] Robertson DW(1966)Treatment of refractory obesity with fenfluramine BMJ 2 205-406
  • [6] Zhang Y(2002)Fenfluramine as a potential antiepileptic drug Epilepsia J Int League Against Epilepsy 43 581-1139
  • [7] Munro JF(1997)Valvular heart disease associated with fenfluramine–phentermine N Engl J Med 337 1419-231
  • [8] Seaton DA(1985)Treatment of self-induced photosensitive epilepsy with fenfluramine N Engl J Med 313 391-619
  • [9] Duncan LJ(1987)Compulsive respiratory stereotypies in children with autistic features: polygraphic recording and treatment with fenfluramine J Autism Dev Disord 17 1131-308
  • [10] Casaer P(2012)Successful use of fenfluramine as an add-on treatment for Dravet syndrome Epilepsia 53 228-14